Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adding zoledronic acid to endocrine therapy in the adjuvant treatment of hormone-sensitive breast cancer in premenopausal women: a new care standard or a provocative idea?

× No keyword cloud information.

3 in total

1. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.

Authors: Nigel J Bundred; Ian D Campbell; Neville Davidson; Richard H DeBoer; Holger Eidtmann; Alain Monnier; Patrick Neven; Gunter von Minckwitz; Joel C Miller; Nora L Schenk; Robert E Coleman
Journal: Cancer Date: 2008-03-01 Impact factor: 6.860

2. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.

Authors: Michael Gnant; Brigitte Mlineritsch; Gero Luschin-Ebengreuth; Franz Kainberger; Helmut Kässmann; Jutta Claudia Piswanger-Sölkner; Michael Seifert; Ferdinand Ploner; Christian Menzel; Peter Dubsky; Florian Fitzal; Vesna Bjelic-Radisic; Günther Steger; Richard Greil; Christian Marth; Ernst Kubista; Hellmut Samonigg; Peter Wohlmuth; Martina Mittlböck; Raimund Jakesz
Journal: Lancet Oncol Date: 2008-08-19 Impact factor: 41.316

3. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.

Authors: John F Forbes; Jack Cuzick; Aman Buzdar; Anthony Howell; Jeffrey S Tobias; Michael Baum
Journal: Lancet Oncol Date: 2008-01 Impact factor: 41.316

3 in total

1 in total

Review 1. Bone Health in Patients with Breast Cancer: Recommendations from an Evidence-Based Canadian Guideline.

Authors: Alexander H G Paterson; Melissa A Shea-Budgell
Journal: J Clin Med Date: 2013-12-17 Impact factor: 4.241

1 in total